Cancer Knows No Borders

Unafraid to tackle cancer disparities across races, Olufunmilayo “Funmi” Olopade has demonstrated that genomics research can make a big impact on public health.

Written byMegan Scudellari
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

THE UNIVERSITY OF CHICAGO MEDICINE COMPREHENSIVE CANCER CENTERIn November 1982, a military officer practicing on the soccer field outside the Nigerian Navy Hospital in Lagos, Nigeria, collapsed and died. Olufunmilayo “Funmi” Olopade, a young, newly minted doctor, was working inside when the man was brought in to the emergency room. “We couldn’t understand why he died,” says Olopade. “That really shocked me, and made me realize that I needed to do more to be able to understand and help people.”

Three months earlier, Olopade had visited her brother, a graduate student at Stanford University, and while in the United States, she flew to Chicago where she interviewed with and was offered a job at Cook County Hospital. At the time, she wasn’t sure she was ready to commit to a medical residency in the U.S. But the day the soldier died, Olopade called Cook County and asked if the position was still available. It was, and 2 months later, she was on a plane to Chicago.

“I think we can democratize how we prevent and treat cancer, so people on the periphery can take advantage of the research going on in the center.”

Olopade quickly rose in the ranks at Cook County, becoming Chief Resident ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies